A detailed history of Satter Management Co., L.P. transactions in Annexon, Inc. stock. As of the latest transaction made, Satter Management Co., L.P. holds 7,406,024 shares of ANNX stock, worth $48.5 Million. This represents 76.44% of its overall portfolio holdings.

Number of Shares
7,406,024
Previous 7,406,024 -0.0%
Holding current value
$48.5 Million
Previous $36.3 Million 20.82%
% of portfolio
76.44%
Previous 71.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.63 - $4.63 $570,500 - $1.62 Million
350,000 Added 4.96%
7,406,024 $33.6 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $9.9 Million - $19.7 Million
2,647,058 Added 60.04%
7,056,024 $27.2 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $9.2 Million - $16.3 Million
2,453,988 Added 125.53%
4,408,966 $27.2 Million
Q4 2020

Feb 11, 2021

BUY
$20.81 - $30.55 $40.7 Million - $59.7 Million
1,954,978 New
1,954,978 $48.9 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Satter Management Co., L.P. Portfolio

Follow Satter Management Co., L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Satter Management Co., L.P., based on Form 13F filings with the SEC.

News

Stay updated on Satter Management Co., L.P. with notifications on news.